| Biological characterization of two novel cathelicidin-derived peptides and identification of structural requirements for their antimicrobial and cell lytic activities B Skerlavaj, R Gennaro, L Bagella, L Merluzzi, A Risso, M Zanetti Journal of Biological Chemistry 271 (45), 28375-28381, 1996 | 319 | 1996 |
| Activation and function of cyclin T–Cdk9 (positive transcription elongation factor-b) in cardiac muscle-cell hypertrophy M Sano, M Abdellatif, H Oh, M Xie, L Bagella, A Giordano, LH Michael, ... Nature medicine 8 (11), 1310-1317, 2002 | 272 | 2002 |
| The retinoblastoma gene family pRb/p105, p107, pRb2/p130 and simian virus-40 large T-antigen in human mesotheliomas A De Luca, A Baldi, V Esposito, CM Howard, L Bagella, P Rizzo, M Caputi, ... Nature medicine 3 (8), 913-916, 1997 | 252 | 1997 |
| From G0 to S phase: A view of the roles played by the retinoblastoma (Rb) family members in the Rb‐E2F pathway A Sun, L Bagella, S Tutton, G Romano, A Giordano Journal of cellular biochemistry 102 (6), 1400-1404, 2007 | 213 | 2007 |
| cDNA sequences of three sheep myeloid cathelicidins L Bagella, M Scocchi, M Zanetti FEBS letters 376 (3), 225-228, 1995 | 142 | 1995 |
| Histone deacetylase inhibitors in the treatment of hematological malignancies and solid tumors M Federico, L Bagella BioMed Research International 2011, 2011 | 138 | 2011 |
| The COOH-terminal region of pRb2/p130 binds to histone deacetylase 1 (HDAC1), enhancing transcriptional repression of the E2F-dependent cyclin A promoter P Stiegler, A De Luca, L Bagella, A Giordano Cancer research 58 (22), 5049-5052, 1998 | 130 | 1998 |
| Activation of MyoD-dependent transcription by cdk9/cyclin T2 C Simone, P Stiegler, L Bagella, B Pucci, C Bellan, G De Falco, ... Oncogene 21 (26), 4137-4148, 2002 | 129 | 2002 |
| Viral infections as a cause of cancer C Carrillo-Infante, G Abbadessa, L Bagella, A Giordano International journal of oncology 30 (6), 1521-1528, 2007 | 127 | 2007 |
| Ezh2 reduces the ability of HDAC1-dependent pRb2/p130 transcriptional repression of cyclin A T Tonini, L Bagella, G D'Andrilli, PP Claudio, A Giordano Oncogene 23 (28), 4930-4937, 2004 | 115 | 2004 |
| A unique domain of pRb2/p130 acts as an inhibitor of Cdk2 kinase activity A De Luca, TK MacLachlan, L Bagella, C Dean, CM Howard, PP Claudio, ... Journal of Biological Chemistry 272 (34), 20971-20974, 1997 | 113 | 1997 |
| Study of viral integration of HPV-16 in young patients with LSIL G Gallo, M Bibbo, L Bagella, A Zamparelli, F Sanseverino, MR Giovagnoli, ... Journal of clinical pathology 56 (7), 532-536, 2003 | 96 | 2003 |
| CDK9/CYCLIN T1 expression during normal lymphoid differentiation and malignant transformation C Bellan, G De Falco, S Lazzi, P Micheli, S Vicidomini, K Schürfeld, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 2004 | 95 | 2004 |
| Importance of Ezh2 polycomb protein in tumorigenesis process interfering with the pathway of growth suppressive key elements T Tonini, G D'Andrilli, A Fucito, L Gaspa, L Bagella Journal of cellular physiology 214 (2), 295-300, 2008 | 87 | 2008 |
| Physical interaction between pRb and cdk9/cyclinT2 complex C Simone, L Bagella, C Bellan, A Giordano Oncogene 21 (26), 4158-4165, 2002 | 86 | 2002 |
| Retinoblastoma tumor-suppressor protein phosphorylation and inactivation depend on direct interaction with Pin1 F Rizzolio, C Lucchetti, I Caligiuri, I Marchesi, M Caputo, AJ Klein-Szanto, ... Cell Death & Differentiation 19 (7), 1152-1161, 2012 | 80 | 2012 |
| Frequent loss of pRb2/p130 in human ovarian carcinoma G D’Andrilli, V Masciullo, L Bagella, T Tonini, C Minimo, GF Zannoni, ... Clinical cancer research 10 (9), 3098-3103, 2004 | 70 | 2004 |
| Cloning of murine CDK9/PITALRE and its tissue‐specific expression in development L Bagella, TK MacLachlan, RJ Buono, MM Pisano, A Giordano, ... Journal of cellular physiology 177 (2), 206-213, 1998 | 68 | 1998 |
| MyoD recruits the cdk9/cyclin T2 complex on myogenic‐genes regulatory regions C Giacinti, L Bagella, PL Puri, A Giordano, C Simone Journal of cellular physiology 206 (3), 807-813, 2006 | 67 | 2006 |
| A small molecule based on the pRb2/p130 spacer domain leads to inhibition of cdk2 activity, cell cycle arrest and tumor growth reduction in vivo L Bagella, A Sun, T Tonini, G Abbadessa, G Cottone, MG Paggi, ... Oncogene 26 (13), 1829-1839, 2007 | 60 | 2007 |
